Experience Using Paxlovid for Patients With Coronavirus Disease 2019 in a Resource-Limited Emergency Department
- PMID: 36153054
- PMCID: PMC9490110
- DOI: 10.1016/j.annemergmed.2022.05.029
Experience Using Paxlovid for Patients With Coronavirus Disease 2019 in a Resource-Limited Emergency Department
References
-
- Gandhi R.T., Malani P.N., Del Rio C. COVID-19 therapeutics for nonhospitalized patients. JAMA. 2022;327:617–618. - PubMed
-
- Morgenstern J. COVID therapy: There is still no evidence for nirmatrelvir/ritonavir (Paxlovid). First10EM. https://first10em.com/covid-therapy-there-is-still-no-evidence-for-nirma...
-
- Ledford H. Hundreds of COVID trials could provide a deluge of new drugs. Nature. 2022;603:25–27. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical